Studying the Expression Efficiencies of Human Clotting Factor IX Analogs, Rationally-designed for Hyper-glycosylation.

Ghasemi, Fahimeh; Khorramizadeh, M Reza; Karkhane, Ali Asghar; Zomorodipour, Alireza.

Afiliação

Ghasemi F; Department of Medical Biotechnology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Khorramizadeh MR; Department of Medical Biotechnology, School of Advanced Technology of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Karkhane AA; Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Endocrinology and Metabolism Research Institute (EMRI), and Zebrafish Core Facility-EMRI, Tehran University of Medical Sciences, Tehran, Iran.
Zomorodipour A; Institute of Industrial and Environmental Biotechnology (IIEB), National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Iran J Pharm Res ; 20(2): 523-535, 2021.

Article em En | MEDLINE | ID: mdl-34567179